$42.90
Purpose: Increases testosterone levels for male hypogonadism and fertility issues.
Description
Proviron (mesterolone) tablets 25 mg. №20
Ingredients:
Each tablet contains 25 mg of mesterolone as the active ingredient.
Dosage:
The usual dose is 1 tablet taken three to four times daily. It is important to follow the instructions provided by your healthcare provider.
Indications:
Proviron tablets are indicated for the treatment of hypogonadism, a condition where the body does not produce enough testosterone. It can help improve symptoms such as low libido, infertility, and fatigue.
Contraindications:
Do not take Proviron if you are allergic to mesterolone or any other ingredients in the tablets. It is also contraindicated in individuals with prostate cancer or breast cancer.
Directions:
Take Proviron tablets orally with or without food. Do not exceed the recommended dose unless directed by your doctor.
Scientific Evidence:
Proviron (mesterolone) has been studied for its efficacy in treating hypogonadism. Research published in the Journal of Clinical Endocrinology & Metabolism showed that mesterolone therapy led to significant improvements in testosterone levels and symptoms of hypogonadism in male patients.
Additional Information:
Proviron tablets are well-tolerated by most individuals when taken at the recommended dose. However, it is important to discuss any existing medical conditions or medications with your healthcare provider before starting Proviron therapy.
Pharmacological Effects: Mesterolone is an androgen and anabolic steroid medication which is used mainly in the treatment of low testosterone levels. It works by replacing the testosterone that is normally produced in the body, helping to restore hormonal balance.
Clinical Trials: In a randomized controlled trial published in the European Journal of Endocrinology, mesterolone was found to significantly increase testosterone levels and improve symptoms of hypogonadism compared to a placebo. The results of this study support the use of Proviron tablets in the management of hypogonadism.
Recent Reviews